
Melton Biomedical International Co., Limited is a technology-driven enterprise specializing in the development and application of gene delivery vector technologies, headquartered in Hong Kong.
Melton's core technology lies in its F gene Defective-Sendai Virus (SeV) Vector, a cutting-edge gene delivery system.
Melton's Mission
Our mission is committed to promoting recombinant Sendai virus vector technology to the world and contributing to the global healthcare sector.